Viral upper respiratory tract infection and Drowsiness

Summary:

Drowsiness is found among people with Viral upper respiratory tract infection, especially for people who are female, 60+ old.

The study analyzes which people have Drowsiness with Viral upper respiratory tract infection. It is created by eHealthMe based on reports of 33 people who have Viral upper respiratory tract infection from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Viral upper respiratory tract infection?

Viral upper respiratory tract infection is found to be associated with 563 drugs and 580 conditions by eHealthMe. Check the latest studies of Viral upper respiratory tract infection.

What is Drowsiness?

Drowsiness is found to be associated with 2,863 drugs and 4,800 conditions by eHealthMe. Check the latest studies of Drowsiness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

33 people who have Viral Upper Respiratory Tract Infection and Drowsiness are studied.

Would you have Drowsiness when you have Viral upper respiratory tract infection?

Gender of people who have Viral Upper Respiratory Tract Infection and experienced Drowsiness *:

female: 63.33 %
male: 36.67 %

Age of people who have Viral Upper Respiratory Tract Infection and experienced Drowsiness *:

Common co-existing conditions for these people *:

Hypersensitivity: 21 people, 63.64%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 4 people, 12.12%
Seasonal Allergy (allergic condition due to certain season): 2 people, 6.06%
Dyspnea (difficult or laboured breathing): 2 people, 6.06%
Oropharyngeal Pain: 2 people, 6.06%
Multiple Allergies (allergy to multiple agents): 2 people, 6.06%
Allergic Respiratory Symptom: 1 person, 3.03%
Diarrhea: 1 person, 3.03%
Hair Loss: 1 person, 3.03%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 3.03%

Common drugs taken by these people *:

Claritin: 11 people, 33.33%
Claritin-D 24 Hour: 8 people, 24.24%
Zyrtec: 3 people, 9.09%
Mucinex: 2 people, 6.06%
Dextromethorphan Polistirex: 1 person, 3.03%
Hydroxyzine: 1 person, 3.03%
Hydrocodone: 1 person, 3.03%
Flonase Sensimist Allergy Relief: 1 person, 3.03%
Fish Oil: 1 person, 3.03%
Femara: 1 person, 3.03%

Common symptoms for these people *:

Drug Ineffective: 7 people, 21.21%
Fatigue (feeling of tiredness): 6 people, 18.18%
Therapeutic Response Unexpected: 4 people, 12.12%
Weakness: 3 people, 9.09%
Insomnia (sleeplessness): 3 people, 9.09%
Dizziness: 2 people, 6.06%
Headache (pain in head): 2 people, 6.06%
Nosebleed (bleeding from nose): 2 people, 6.06%
Itching: 2 people, 6.06%
Discomfort: 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Viral upper respiratory tract infection (7,720 reports)
Drowsiness (269,040 reports)

All the drugs that are associated with Drowsiness:

Drowsiness (2,863 drugs)

All the conditions that are associated with Drowsiness:

Drowsiness (4,800 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Drowsiness and Viral upper respiratory tract infection, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.